Blog, Business

India mandates faster reporting of drug side effects

India’s drug regulator has sharply tightened its pharmacovigilance rules, requiring companies to report serious adverse drug effects within 15 days and other reactions within 90 days. Effective 1 February, the new DCGI guidance aims to strengthen oversight of the country’s pharmaceutical industry.

Scroll to Top